BPC 157 FDA Approval Unlikely Due to Patent Economics Stefano M. Sinicropi, MD posted on the topic LinkedIn FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and BPC 157: Miracle Healing Peptide or Hidden Danger? BPC 157: Miracle Healing Peptide or Hidden Danger? BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification